Heba Mostafa

Research output

Research output per year 2011 2021 2022 2023 2024

• 90 Article
• 5 Letter
• 5 Review article
• 2 Comment/debate
• 1 More
  • 1 Conference contribution

Research output per year

Research output per year

Search results

• 2024

  Is It Possible to Test for Viral Infectiousness? The Use Case of (SARS-CoV-2)

  Mostafa, H. H., Mar 2024, In: Clinics in laboratory medicine. 44, 1, p. 85-93 9 p.

  Research output: Contribution to journal › Review article › peer-review

• Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients

  Traut, C. C., Jones, J., Sanders, R. A., Clark, L. R., Hamill, M. M., Stavrakis, G., Sop, J., Beckey, T. P., Keller, S., Gilliams, E. A., Cochran, W. V., Laeyendecker, O. B., Manabe, Y. C., Mostafa, H., Thomas, D. L., Hansoti, B., Gebo, K. A. & Blankson, J. N., Jan 15 2024, In: Journal of Infectious Diseases. 229, 1, p. 54-58 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Orthopoxvirus 100%
  • HLA-A2 Antigen 44%
  • T-Lymphocytes 40%
  • Vaccinia virus 38%
  • Epitopes 27%

• Reduced control of SARS-CoV-2 infection associates with lower mucosal antibody responses in pregnancy

  Clair, L. A. S., Eldesouki, R. E., Sachithanandham, J., Yin, A., Fall, A., Morris, C. P., Norton, J. M., Abdullah, O., Dhakal, S., Barranta, C., Golding, H., Bersoff-Matcha, S. J., Pilgrim-Grayson, C., Berhane, L., Cox, A., Burd, I., Pekosz, A., Mostafa, H., Klein, E. & Klein, S., Mar 2024, In: mSphere. 9, 3

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection

  Farjo, M., Koelle, K., Martin, M. A., Gibson, L. L., Walden, K. K. O., Rendon, G., Fields, C. J., Alnaji, F. G., Gallagher, N., Luo, C. H., Mostafa, H. H., Manabe, Y. C., Pekosz, A., Smith, R. L., McManus, D. D. & Brooke, C. B., Jan 2024, In: Journal of virology. 98, 1

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Nose 36%
  • infection 35%
  • saliva 34%
  • Infections 32%
• 2023

  Accuracy of Expired BinaxNOW Rapid Antigen Tests

  Vaeth, M. J. E., Abdullah, O., Cheema, M., Sun, K., Elhabashy, M., Mitchell, A., Foyez, M., Talla, M., Cheema, A., Locke, C., Kantsiper, M., Pekosz, A., Mostaf, H. H. & Siddiqui, Z. K., Aug 2023, In: Microbiology Spectrum. 11, 4

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • antigen 100%
  • antigens 64%
  • Limit of Detection 56%
  • Antigens 54%
  • antigen detection 48%

• An increase in enterovirus D68 circulation and viral evolution during a period of increased influenza like illness, The Johns Hopkins Health System, USA, 2022

  Fall, A., Han, L., Abdullah, O., Norton, J. M., Eldesouki, R. E., Forman, M., Morris, C. P., Klein, E. & Mostafa, H. H., Mar 2023, In: Journal of Clinical Virology. 160, 105379.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Human Enterovirus D 100%
  • Human Influenza 56%
  • Health 29%
  • Viral Load 25%
  • Oxygen 18%

• Characterizing SARS-CoV-2 Transcription of Subgenomic and Genomic RNAs During Early Human Infection Using Multiplexed Droplet Digital Polymerase Chain Reaction

  Hwang, H. S., Lo, C. M., Murphy, M., Grudda, T., Gallagher, N., Luo, C. H., Robinson, M. L., Mirza, A., Conte, M., Conte, A., Zhou, R., Vergara, C., Brooke, C. B., Pekosz, A., Mostafa, H. H., Manabe, Y. C., Thio, C. L. & Balagopal, A., Apr 15 2023, In: Journal of Infectious Diseases. 227, 8, p. 981-992 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • RNA 53%
  • Polymerase Chain Reaction 45%
  • Infections 37%

• Clinical performance evaluation of the Aptima viral assays for the quantitation of HIV-1, HCV, and HBV in plasma samples

  Lewis, S., Morehead, E., Cheung, H. & Mostafa, H. H., Jul 2023, In: Diagnostic Microbiology and Infectious Disease. 106, 3, 115951.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • HIV-1 100%

• Comparison of nucleocapsid antigen with strand-specific reverse-transcription PCR for monitoring SARS-CoV-2 infection

  Chang-Graham, A. L., Sahoo, M. K., Huang, C. H., Solis, D., Sibai, M., August, G., Calayag, L., Kenji, O. M., Shi, R. Z., Mostafa, H. H., Lei, G. S., Relich, R. F. & Pinsky, B. A., Jul 2023, In: Journal of Clinical Virology. 164, 105468.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Nucleocapsid 89%
  • Reverse Transcription 59%
  • Antigens 43%
  • Confidence Intervals 40%

• COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program during the Omicron Surge

  Cochran, W., Salto-Alejandre, S., Barker, L., Langlee, J., Freed, K., Carter, D., Bannon, J., Goddard, D., Mostafa, H., Werbel, W., Shah, P., Segev, D., Brennan, D. & Avery, R., Feb 1 2023, In: Transplantation. 107, 2, p. E60-E61

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Development of an amplicon-based sequencing approach in response to the global emergence of mpox

  Chen, N. F. G., Chaguza, C., Gagne, L., Doucette, M., Smole, S., Buzby, E., Hall, J., Ash, S., Harrington, R., Cofsky, S., Clancy, S., Kapsak, C. J., Sevinsky, J., Libuit, K., Park, D. J., Hemarajata, P., Garrigues, J. M., Green, N. M., Sierra-Patev, S., Carpenter-Azevedo, K., & 51 othersHuard, R. C., Pearson, C., Incekara, K., Nishimura, C., Huang, J. P., Gagnon, E., Reever, E., Razeq, J., Muyombwe, A., Borges, V., Ferreira, R., Sobral, D., Duarte, S., Santos, D., Vieira, L., Gomes, J. P., Aquino, C., Savino, I. M., Felton, K., Bajwa, M., Hayward, N., Miller, H., Naumann, A., Allman, R., Greer, N., Fall, A., Mostafa, H. H., McHugh, M. P., Maloney, D. M., Dewar, R., Kenicer, J., Parker, A., Mathers, K., Wild, J., Cotton, S., Templeton, K. E., Churchwell, G., Lee, P. A., Pedrosa, M., McGruder, B., Schmedes, S., Plumb, M. R., Wang, X., Barcellos, R. B., Godinho, F. M. S., Salvato, R. S., Ceniseros, A., Breban, M. I., Grubaugh, N. D., Gallagher, G. R. & Vogels, C. B. F., Jun 2023, In: PLoS biology. 21, 6, e3002151.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Monkeypox virus 100%
  • Coronavirus 98%
  • Pipeline 90%
  • Genome 53%
  • Disease Outbreaks 52%

• Dissemination and genome characterization of a human adenovirus F41 in a patient with B-Cell lymphoma

  Fall, A., Campodónico, V. L., Howard, C., Gallagher, N., Bailey, G., Kajon, A. E. & Mostafa, H. H., Dec 2023, In: Virology Journal. 20, 1, 141.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Human Adenoviruses 100%
  • B-Cell Lymphoma 78%
  • Genome 51%
  • Cryptogenic Cirrhosis 39%
  • Adenoviridae Infections 34%

• Effectiveness of COVID-19 mRNA Vaccines in Preventing COVID-19-Associated Outpatient Visits and Hospitalizations Among American Indian and Alaska Native Persons, January–November 2021: A Test-Negative Case–Control Analysis Using Surveillance Data

  Lutz, C. S., Hartman, R. M., Vigil, D. E., Britton, A., Burrage, A. B., Campbell, A. P., Close, R. M., Desnoyers, C., Dobson, J., Garcia, S., Halasa, N., Honie, E., Kobayashi, M., McMorrow, M., Mostafa, H. H., Parker, D., Pohl, K., Prill, M. M., Richards, J., Roessler, K. C., & 7 othersSutcliffe, C. G., Taylor, K., Swango-Wilson, A., Va, P., Verani, J. R., Singleton, R. J. & Hammitt, L. L., Apr 1 2023, In: Open Forum Infectious Diseases. 10, 4, ofad172.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Alaska Natives 100%
  • Coronavirus 87%
  • North American Indians 84%
  • Outpatients 52%
  • Vaccines 52%

• Enterovirus characterized from cerebrospinal fluid in a cohort from the Eastern United States

  Fall, A., Forman, M., Morris, C. P., Gniazdowski, V., Luo, C. H., Hanlon, A., Miller, H., Bergman, Y. & Mostafa, H. H., Apr 2023, In: Journal of Clinical Virology. 161, 105401.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Enterovirus 100%
  • Cerebrospinal Fluid 75%
  • Whole Genome Sequencing 37%
  • Genetic Recombination 20%
  • Microbiology 11%

• Evaluating the impact of point-of-care HIV viral load assessment on linkage to care in Baltimore, MD: a randomized controlled trial

  Bayan, M. H., Smalls, T., Boudreau, A., Mirza, A. W., Pasco, C., Demko, Z. O., Rothman, R. E., Hsieh, Y. H., Eshleman, S. H., Mostafa, H. H., Gonzalez-Jimenez, N., Chavez, P. R., Emerson, B., Delaney, K. P., Daugherty, D., MacGowan, R. J., Manabe, Y. C. & Hamill, M. M., Dec 2023, In: BMC infectious diseases. 23, 1, 570.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Baltimore 100%
  • Point-of-Care Systems 88%
  • Viral Load 75%
  • HIV 53%
  • Randomized Controlled Trials 52%

• Evolution of Influenza A(H3N2) Viruses in 2 Consecutive Seasons of Genomic Surveillance, 2021–2023

  Fall, A., Han, L., Yunker, M., Gong, Y. N., Li, T. J., Norton, J. M., Abdullah, O., Rothman, R. E., Fenstermacher, K. Z. J., Paul Morris, C., Pekosz, A., Klein, E. & Mostafa, H. H., Dec 1 2023, In: Open Forum Infectious Diseases. 10, 12, ofad577.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • H3N2 Subtype Influenza A Virus 100%
  • Influenza A virus 78%
  • Human Influenza 46%
  • Hemagglutinins 34%
  • Vaccines 15%

• Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome

  Robinson, M. L., Morris, C. P., Betz, J. F., Zhang, Y., Bollinger, R., Wang, N., Thiemann, D. R., Fall, A., Eldesouki, R. E., Norton, J. M., Gaston, D. C., Forman, M., Luo, C. H., Zeger, S. L., Gupta, A., Garibaldi, B. T. & Mostafa, H. H., May 1 2023, In: Clinical Infectious Diseases. 76, 9, p. 1539-1549 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Severe Acute Respiratory Syndrome 87%
  • Coronavirus 85%
  • Inpatients 54%
  • Hepatitis D 33%

• Lead Time to Recurrence after Posttreatment Plasma and Saliva HPV DNA Testing in Patients with Low-Risk HPV Oropharynx Cancer

  Califano, J., Yousef, A., Mostafa, H., Valsamakis, A., Zhang, X., Batis, N., Varghese, C., Parish, J., Forman, M., Jarrett, J., Messer, K. & Mehanna, H., Sep 14 2023, In: JAMA Otolaryngology - Head and Neck Surgery. 149, 9, p. 812-819 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Oropharyngeal Neoplasms 100%
  • Recurrence 43%
  • DNA 42%
  • Phase III Clinical Trials 20%
  • Cohort Studies 11%

• Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization

  Morris, C. P., Eldesouki, R. E., Sachithanandham, J., Fall, A., Norton, J. M., Abdullah, O., Gallagher, N., Li, M., Pekosz, A., Klein, E. Y. & Mostafa, H. H., Apr 1 2023, In: Clinical Infectious Diseases. 76, 7, p. 1276-1284 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cell Culture Techniques 100%
  • Coronavirus 82%
  • Infections 62%
  • Viruses 58%
  • Severe Acute Respiratory Syndrome 56%

• Respiratory Adenovirus Quantification with a Droplet Digital Polymerase Chain Reaction (ddPCR) Assay

  Abdullah, O., Fall, A., Forman, M., Howard, C., Klein, E. & Mostafa, H. H., May 2023, In: Microbiology Spectrum. 11, 3

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Mastadenovirus 100%
  • Human Adenoviruses 89%
  • polymerase chain reaction 77%
  • Adenoviridae 77%
  • droplets 63%

• Risk Factors for Hospitalization and Effect of Immunosuppression on Clinical Outcomes among an Urban Cohort of Patients with Mpox

  Garneau, W. M., Jones, J. L., Dashler, G. M., Mostafa, H. H., Judson, S. D., Kwon, N., Hamill, M. M., Gilliams, E. A., Rudolph, D. S., Keruly, J. C., Fall, A., Klein, E. Y., Hansoti, B. & Gebo, K. A., Dec 1 2023, In: Open Forum Infectious Diseases. 10, 12, ofad533.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Immunosuppression 100%
  • Hospitalization 81%
  • HIV 65%
  • CD4 Lymphocyte Count 32%
  • Odds Ratio 20%

• Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) exposure investigations using genomic sequencing among healthcare workers and patients in a large academic center

  Smith, L., Morris, C. P., Jibowu, M. H., Fallon, S., Ray, S. C., Cosgrove, S. E., Curless, M. S., Fabre, V., Karaba, S. M., Maragakis, L. L., Milstone, A. M., Sick-Samuels, A. C., Trexler, P., Mostafa, H. H. & Rock, C., May 2023, In: Infection control and hospital epidemiology. 44, 5, p. 798-801 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Health Personnel 68%
  • Viruses 53%

• Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis

  Klein, E. Y., Fall, A., Norton, J. M., Eldesouki, R. E., Abdullah, O., Han, L., Yunker, M. & Mostafa, H. H., Aug 2023, In: Journal of Clinical Virology. 165, 105500.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Kidney Diseases 35%
  • Infections 32%
  • Immunosuppression 30%
  • Lung Diseases 30%

• Validation and implementation of an orthopoxvirus qualitative real-time PCR for the diagnosis of monkeypox in the clinical laboratory

  Uhteg, K. & Mostafa, H. H., Jan 2023, In: Journal of Clinical Virology. 158, 105327.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Monkeypox 100%
  • Monkeypox virus 99%
  • Orthopoxvirus 90%
  • Real-Time Polymerase Chain Reaction 46%
  • Temperature 14%
• 2022

  Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection

  Park, H. S., Shapiro, J. R., Sitaras, I., Woldemeskel, B. A., Garliss, C. C., Dziedzic, A., Sachithanandham, J., Jedlicka, A. E., Caputo, C. A., Rousseau, K. E., Thakar, M., Suwanmanee, S., Hauk, P., Aliyu, L., Majewska, N. I., Koley, S., Patel, B., Broderick, P., Mosnaim, G., Heath, S. L., & 18 othersSpivak, E. S., Shenoy, A., Bloch, E. M., Gniadek, T. J., Shoham, S., Casadevall, A., Hanley, D., Cox, A. L., Laeyendecker, O., Betenbaugh, M. J., Cramer, S. M., Mostafa, H. H., Pekosz, A., Blankson, J. N., Klein, S. L., Tobian, A. A. R., Sullivan, D. & Gebo, K. A., Mar 8 2022, In: JCI Insight. 7, 5, e155944.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Adaptive Immunity 69%
  • Neutralizing Antibodies 50%
  • Viruses 45%
  • Vaccination 40%

• Analysis of Clinical Outcomes of Pregnant Patients Treated With Nirmatrelvir and Ritonavir for Acute SARS-CoV-2 Infection

  Garneau, W. M., Jones-Beatty, K., Ufua, M. O., Mostafa, H. H., Klein, S. L., Burd, I. & Gebo, K. A., Nov 1 2022, In: JAMA Network Open. 5, 11, p. e2244141

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Ritonavir 86%
  • Infections 32%
  • Comorbidity 9%
  • Pregnancy 7%

• An Update on Severe Acute Respiratory Syndrome Coronavirus 2 Diversity in the US National Capital Region: Evolution of Novel and Variants of Concern

  Morris, C. P., Luo, C. H., Amadi, A., Schwartz, M., Gallagher, N., Ray, S. C., Pekosz, A. & Mostafa, H. H., Apr 15 2022, In: Clinical Infectious Diseases. 74, 8, p. 1419-1428 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Metadata 28%
  • Specimen Handling 26%
  • Genome 26%

• Association of E484K Spike Protein Mutation With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Vaccinated Persons: Maryland, January-May 2021

  Feder, K. A., Patel, A., Vepachedu, V. R., Dominguez, C., Keller, E. N., Klein, L., Kim, C., Blood, T., Hyun, J., Williams, T. W., Feldman, K. A., Mostafa, H. H., Morris, C. P., Ravel, J., Duwell, M., Blythe, D. & Myers, R., Jun 1 2022, In: Clinical Infectious Diseases. 74, 11, p. 2053-2056 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 90%
  • Coronavirus 87%
  • Mutation 39%
  • Vaccination 27%
  • Proteins 25%

• Characterizing the microbiota of instrumentation in ophthalmology clinics during and beyond the COVID-19 pandemic

  Mahjoub, H., Zhang, S. X., Wang, J., Memon, W., Mostafa, H. & Breazzano, M. P., Aug 2022, In: Graefe's Archive for Clinical and Experimental Ophthalmology. 260, 8, p. 2585-2590 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Pandemics 72%
  • Ophthalmology 70%
  • Microbiota 67%
  • Disinfection 53%

• Circulation of Enterovirus D68 during Period of Increased Influenza-Like Illness, Maryland, USA, 2021

  Fall, A., Gallagher, N., Paul Morris, C., Norton, J. M., Pekosz, A., Klein, E. & Mostafa, H. H., Jul 2022, In: Emerging infectious diseases. 28, 7, p. 1525-1527 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Human Enterovirus D 100%
  • Human Influenza 56%
  • Genome 20%

• Circulation of Non-SARS-CoV-2 Respiratory Pathogens and Coinfection with SARS-CoV-2 Amid the COVID-19 Pandemic

  Uhteg, K., Amadi, A., Forman, M. & Mostafa, H. H., Mar 2022, In: Open Forum Infectious Diseases. 9, 3, ofab618.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Pandemics 82%
  • Coinfection 75%
  • Respiratory Syncytial Viruses 19%

• Clinical Utility of the Signal-to-Cutoff Ratio of Reactive HIV Antigen/Antibody Screening Tests in Guiding Emergency Physician Management

  White, D. A. E., Anderson, E. S., Basham, K., Ng, V. L., Russell, C., Lyons, M. S., Powers-Fletcher, M. V., Giordano, T. P., Muldrew, K. L., Siatecka, H., Hsieh, Y. H., Dashler, G., Carroll, K. C., Mostafa, H. H. & Rothman, R. E., Mar 1 2022, In: Journal of Acquired Immune Deficiency Syndromes. 89, 3, p. 332-339 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • HIV Antigens 100%
  • HIV Antibodies 86%
  • Emergencies 51%
  • HIV 46%
  • Physicians 42%

• Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients

  Dioverti, M. V., Gaston, D. C., Morris, C. P., Huff, C. A., Jain, T., Jones, R., Anders, V., Lederman, H., Saunders, J., Mostafa, H. H. & Avery, R. K., Jun 1 2022, In: Open Forum Infectious Diseases. 9, 6, ofac064.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • GS-5734 100%
  • SARS Virus 69%
  • B-Lymphocytes 36%
  • Severe Acute Respiratory Syndrome 30%
  • Coronavirus 29%

• COVID-19 Clinical Outcomes in Solid Organ Transplant Recipients During the Omicron Surge

  Cochran, W., Shah, P., Barker, L., Langlee, J., Freed, K., Boyer, L., Scott Anderson, R., Belden, M., Bannon, J., Kates, O. S., Permpalung, N., Mostafa, H., Segev, D. L., Brennan, D. C. & Avery, R. K., Jul 1 2022, In: Transplantation. 106, 7, p. E346-E347

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness

  Ke, R., Martinez, P. P., Smith, R. L., Gibson, L. L., Mirza, A., Conte, M., Gallagher, N., Luo, C. H., Jarrett, J., Zhou, R., Conte, A., Liu, T., Farjo, M., Walden, K. K. O., Rendon, G., Fields, C. J., Wang, L., Fredrickson, R., Edmonson, D. C., Baughman, M. E., & 19 othersChiu, K. K., Choi, H., Scardina, K. R., Bradley, S., Gloss, S. L., Reinhart, C., Yedetore, J., Quicksall, J., Owens, A. N., Broach, J., Barton, B., Lazar, P., Heetderks, W. J., Robinson, M. L., Mostafa, H. H., Manabe, Y. C., Pekosz, A., McManus, D. D. & Brooke, C. B., May 2022, In: Nature microbiology. 7, 5, p. 640-652 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Viral Load 65%
  • Virus Shedding 60%
  • Infections 32%
  • Viruses 30%

• Efficacy of an HSV-1 Neuro-Attenuated Vaccine in Mice Is Reduced by Preventing Viral DNA Replication

  Wang, H., Davido, D. J., Mostafa, H. H. & Morrison, L. A., May 2022, In: Viruses. 14, 5, 869.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Attenuated Vaccines 100%
  • Viral DNA 90%
  • Human Herpesvirus 1 88%
  • DNA Replication 80%
  • Viruses 43%

• Evaluation of Four Point of Care (POC) Antigen Assays for the Detection of the SARS-CoV-2 Variant Omicron

  Hardick, J., Gallagher, N., Sachithanandham, J., Fall, A., Siddiqui, Z., Pekosz, A., Manabe, Y. C. & Mostafa, H. H., Jun 2022, In: Microbiology Spectrum. 10, 3

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • severe acute respiratory syndrome 100%
  • SARS Virus 96%
  • antigen 75%
  • Point-of-Care Systems 73%
  • assay 55%

• Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays

  Quinton, M., Geahr, M., Gluck, L., Jarrett, J. & Mostafa, H. H., Jun 2022, In: Journal of Clinical Virology. 150-151, 105164.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Respiratory Syncytial Viruses 79%
  • Human Influenza 54%
  • Standard of Care 16%
  • Microbiology 8%

• Importance of internal controls to monitor adequate specimen collection: The case of orthopoxvirus real-time PCR

  Mostafa, H. H., Nov 2022, In: Journal of Clinical Virology. 156, 105294.

  Research output: Contribution to journal › Letter › peer-review

• Infection with the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated with Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals

  Huai Luo, C., Paul Morris, C., Sachithanandham, J., Amadi, A., Gaston, D. C., Li, M., Swanson, N. J., Schwartz, M., Klein, E. Y., Pekosz, A. & Mostafa, H. H., Jul 1 2022, In: Clinical Infectious Diseases. 75, 1, p. E715-E725

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Hepatitis D 68%
  • Viruses 51%
  • Infections 37%

• Large Scale SARS-CoV-2 Molecular Testing and Genomic Surveillance Reveal Prolonged Infections, Protracted RNA shedding, and Viral Reinfections

  Morris, C. P., Luo, C. H., Sachithanandham, J., Li, M., Schwartz, M., Gaston, D. C., Gniazdowski, V., Giraldo-Castillo, N., Amadi, A., Norton, J. M., Wright, W. F., Klein, E. Y., Pekosz, A. & Mostafa, H. H., Apr 11 2022, In: Frontiers in Cellular and Infection Microbiology. 12, 809407.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Virus Shedding 91%
  • Viral RNA 74%
  • Infections 32%
  • Whole Genome Sequencing 26%

• Limitations of Molecular and Antigen Test Performance for SARS-CoV-2 in Symptomatic and Asymptomatic COVID-19 Contacts

  Robinson, M. L., Mirza, A., Gallagher, N., Boudreau, A., Jacinto, L. G., Yu, T., Norton, J., Luo, C. H., Conte, A., Zhou, R., Kafka, K., Hardick, J., McManus, D. D., Gibson, L. L., Pekosz, A., Mostafa, H. H. & Manabe, Y. C., Jul 2022, In: Journal of clinical microbiology. 60, 7

  Research output: Contribution to journal › Article › peer-review

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Antigens 49%
  • Nucleic Acids 32%
  • Reverse Transcription 19%

• Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue Distribution

  Ke, R., Martinez, P. P., Smith, R. L., Gibson, L. L., Achenbach, C. J., McFall, S., Qi, C., Jacob, J., Dembele, E., Bundy, C., Simons, L. M., Ozer, E. A., Hultquist, J. F., Lorenzo-Redondo, R., Opdycke, A. K., Hawkins, C., Murphy, R. L., Mirza, A., Conte, M., Gallagher, N., & 23 othersLuo, C. H., Jarrett, J., Conte, A., Zhou, R., Farjo, M., Rendon, G., Fields, C. J., Wang, L., Fredrickson, R., Baughman, M. E., Chiu, K. K., Choi, H., Scardina, K. R., Owens, A. N., Broach, J., Barton, B., Lazar, P., Robinson, M. L., Mostafa, H. H., Manabe, Y. C., Pekosz, A., McManus, D. D. & Brooke, C. B., Jul 1 2022, In: Open Forum Infectious Diseases. 9, 7, ofac192.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Virus Shedding 100%
  • Severe Acute Respiratory Syndrome 95%
  • Coronavirus 93%
  • Tissue Distribution 80%
  • Vaccines 55%

• Mitigation of SARS-CoV-2 transmission at a large public university

  Ranoa, D. R. E., Holland, R. L., Alnaji, F. G., Green, K. J., Wang, L., Fredrickson, R. L., Wang, T., Wong, G. N., Uelmen, J., Maslov, S., Weiner, Z. J., Tkachenko, A. V., Zhang, H., Liu, Z., Ibrahim, A., Patel, S. J., Paul, J. M., Vance, N. P., Gulick, J. G., Satheesan, S. P., & 129 othersGalvan, I. J., Miller, A., Grohens, J., Nelson, T. J., Stevens, M. P., Hennessy, P. M., Parker, R. C., Santos, E., Brackett, C., Steinman, J. D., Fenner, M. R., Dohrer, K., DeLorenzo, M., Wilhelm-Barr, L., Brauer, B. R., Best-Popescu, C., Durack, G., Wetter, N., Kranz, D. M., Breitbarth, J., Simpson, C., Pryde, J. A., Kaler, R. N., Harris, C., Vance, A. C., Silotto, J. L., Johnson, M., Valera, E. A., Anton, P. K., Mwilambwe, L., Bryan, S. P., Stone, D. S., Young, D. B., Ward, W. E., Lantz, J., Vozenilek, J. A., Bashir, R., Moore, J. S., Garg, M., Cooper, J. C., Snyder, G., Lore, M. H., Yocum, D. L., Cohen, N. J., Novakofski, J. E., Loots, M. J., Ballard, R. L., Band, M., Banks, K. M., Barnes, J. D., Bentea, I., Black, J., Busch, J., Conte, A., Conte, M., Curry, M., Eardley, J., Edwards, A., Eggett, T., Fleurimont, J., Foster, D., Fouke, B. W., Gallagher, N., Gastala, N., Genung, S. A., Glueck, D., Gray, B., Greta, A., Healy, R. M., Hetrick, A., Holterman, A. A., Ismail, N., Jasenof, I., Kelly, P., Kielbasa, A., Kiesel, T., Kindle, L. M., Lipking, R. L., Manabe, Y. C., Mayes, J., McGuffin, R., McHenry, K. G., Mirza, A., Moseley, J., Mostafa, H. H., Mumford, M., Munoz, K., Murray, A. D., Nolan, M., Parikh, N. A., Pekosz, A., Pflugmacher, J., Phillips, J. M., Pitts, C., Potter, M. C., Quisenberry, J., Rear, J., Robinson, M. L., Rosillo, E., Rye, L. N., Sherwood, M. E., Simon, A., Singson, J. M., Skadden, C., Skelton, T. H., Smith, C., Stech, M., Thomas, R., Tomaszewski, M. A., Tyburski, E. A., Vanwingerden, S., Vlach, E., Watkins, R. S., Watson, K., White, K. C., Killeen, T. L., Jones, R. J., Cangellaris, A. C., Martinis, S. A., Vaid, A., Brooke, C. B., Walsh, J. T., Elbanna, A., Sullivan, W. C., Smith, R. L., Goldenfeld, N., Fan, T. M., Hergenrother, P. J. & Burke, M. D., Dec 2022, In: Nature communications. 13, 1, 3207.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Compliance 81%
  • Communication 61%
  • Accidental Falls 26%
  • saliva 20%

• Orthopoxvirus Testing Challenges for Persons in Populations at Low Risk or Without Known Epidemiologic Link to Monkeypox — United States, 2022

  Minhaj, F. S., Petras, J. K., Brown, J. A., Mangla, A. T., Russo, K., Willut, C., Lee, M., Beverley, J., Harold, R., Milroy, L., Pope, B., Gould, E., Beeler, C., Schneider, J., Mostafa, H. H., Godfred-Cato, S., Click, E. S., Borah, B. F., Galang, R. R., Cash-Goldwasser, S., & 18 othersWong, J. M., McCormick, D. W., Yu, P. A., Shelus, V., Carpenter, A., Schatzman, S., Lowe, D., Townsend, M. B., Davidson, W., Wynn, N. T., Satheshkumar, P. S., O’Connor, S. M., O’Laughlin, K., Rao, A. K., McCollum, A. M., Negrón, M. E., Hutson, C. L. & Salzer, J. S., 2022, In: MMWR Recommendations and Reports. 71, 36, p. 1155-1158 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Monkeypox 100%
  • Orthopoxvirus 90%

• Point-of-Care Platform for Rapid Multiplexed Detection of SARS-CoV-2 Variants and Respiratory Pathogens

  Trick, A. Y., Chen, F. E., Chen, L., Lee, P. W., Hasnain, A. C., Mostafa, H. H., Carroll, K. C. & Wang, T. H., Jun 2022, In: Advanced Materials Technologies. 7, 6, 2101013.

  Research output: Contribution to journal › Article › peer-review

  • Pathogens 100%
  • Chain Reaction 73%
  • Screening 68%
  • Mutation 62%
  • Patient treatment 56%

• Proceedings of the Clinical Microbiology Open 2018 and 2019 - a Discussion about Emerging Trends, Challenges, and the Future of Clinical Microbiology

  the American Society for Microbiology (ASM) Clinical and Public Health Microbiology Committee and the ASM Corporate Council, Jul 2022, In: Journal of clinical microbiology. 60, 7

  Research output: Contribution to journal › Review article › peer-review

  • Microbiology 100%
  • Pandemics 30%
  • Coronavirus 27%
  • Industry 13%
  • Big Data 9%

• Progressive Development of Cefiderocol Resistance in Escherichia coli during Therapy is Associated with an Increase in bla_NDM-5Copy Number and Gene Expression

  Simner, P. J., Mostafa, H. H., Bergman, Y., Ante, M., Tekle, T., Adebayo, A., Beisken, S., Dzintars, K. & Tamma, P. D., Jul 1 2022, In: Clinical Infectious Diseases. 75, 1, p. 47-54 8 p.

  Research output: Contribution to journal › Article › peer-review

  • cefiderocol 100%
  • Escherichia coli 36%
  • Gene Expression 30%
  • Whole Genome Sequencing 19%
  • ceftazidime drug combination avibactam 14%

• Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Shedding in a Patient With AIDS: Case Report and Review of the Literature

  Peters, J. L., Fall, A., Langerman, S. D., Asmar, M. E., Nakazawa, M., Mustapha, A., Tobian, A. A. R., Mostafa, H. H. & Blankson, J. N., Sep 2022, In: Open Forum Infectious Diseases. 9, 9, ofac479.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Acquired Immunodeficiency Syndrome 64%
  • Hepatitis Delta Virus 54%
  • Infections 37%

• SARS-CoV-2 infections in mRNA vaccinated individuals are biased for viruses encoding spike E484K and associated with reduced infectious virus loads that correlate with respiratory antiviral IgG levels

  Mostafa, H. H., Luo, C. H., Morris, C. P., Li, M., Swanson, N. J., Amadi, A., Gallagher, N. & Pekosz, A., Jun 2022, In: Journal of Clinical Virology. 150-151, 105151.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Antiviral Agents 58%
  • Immunoglobulin G 51%
  • Viruses 45%
  • Messenger RNA 38%